KnowTheStock
Log inCreate free account

Merck & Co Inc

MRK
S&P 500Dow 30NEW YORK STOCK EXCHANGE INC.
$129.38last close · market cap 319.57 Billion
Compare with…
57.1SCORE / 100
Our verdictSELLModerate Growth but DecliningQtr Ending 2026-06-30 · trend negative

Why Sell

Balance sheet is strong; income statement and cash flow are moderate.

Next earnings: 2026-10-29 (BMO), EPS Forecast: $2.12

What is strong
  • Debt Ratio is 0.27
  • Total Debt to Total Assets Ratio is 0.42
What to watch
  • Revenue Growth is 4.64%
  • Operating Income Growth is -64.76%
  • Net Income Growth is -80.66%
  • Earnings Per Share (EPS) Growth is -80.71%
  • Net Margin is 4.77%
  • Current Asset to Current Liability Ratio is 1.32
  • Current Debt to Net Income Ratio not available
  • Cash from Operations Growth is 7.73%
  • Capital Expenditure is High
  • Net Increase in Cash is Negative

What changed

Score by quarter

Downgraded from Buy to Sell in the Mar 2026 quarter: 70.4 → 59.2 (-11.2). This quarter: -2.1.

50607080Sep 2022Jun 2026

What the score is made of

Income statement50.0 -3.8
Balance sheet76.3 +0.0
Cash flow46.1 +0.0

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)66.57 Billion4.64 % growth
EPS1.25-80.71 % growth
Profit margin4.77 %Profit per $1 of sales
P-E ratio—Not available
Market cap319.57 BillionShares × price
Debt-equity ratio1.29Leverage
Dividend3.36Per share, annual
Next earnings2026-10-29BMO · EPS forecast $2.12
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About Merck & Co Inc

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.

Employees
67,000
Exchange
NEW YORK STOCK EXCHANGE INC.
merck.com

Similar stocks

Loading…